{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-147884","form_type":"8-K","ticker":"MRKR","cik":"0001094038","company_name":"Marker Therapeutics, Inc.","filed_at":"2021-12-09T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.463721+00:00","generated_at":"2026-06-28T02:19:19.432425+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Marker Therapeutics appoints Katharine Knobil, M.D., to Board of Directors","bullets":["Appointment effective December 8, 2021; Dr. Knobil will serve until 2022 annual meeting.","Annual cash compensation of $40,000 paid quarterly; initial option for 125,000 shares vesting monthly over three years.","Dr. Knobil brings 20 years of leadership at GlaxoSmithKline; currently CMO at Agilent Technologies."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-147884","json":"https://secwatch.observer/filing/0001104659-21-147884.json","markdown":"https://secwatch.observer/filing/0001104659-21-147884.md","text":"https://secwatch.observer/filing/0001104659-21-147884.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1094038/000110465921147884/0001104659-21-147884-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1094038/000110465921147884/tm2134930d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T02:19:19.432425+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f2493eb48d","claim":"Katharine Knobil was appointed as Director at Marker Therapeutics, Inc..","evidence_excerpt":"Effective December 8, 2021, the Board of Directors (the “ Board ”) of Marker Therapeutics, Inc. (the “ Company ”) appointed Katharine Knobil, M.D. as a member of the Board","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1094038/000110465921147884/0001104659-21-147884-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}